Novo Nordisk A/S won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co.
www.bloomberg.com
#Novo #Nordisk #Approval #Wegovy #Obesity #Pill
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
